Idorsia Pharmaceuticals Ltd
ActiveLimited or Corporation721001 - Research and experimental development in the pharmaceutical industryidorsia.com
Pharmaceutical ManufacturingPatients in need of innovative therapeutic options.
Idorsia Pharmaceuticals Ltd is a Swiss AG registered in Allschwil, BL. Its registered activity falls under Research and experimental development in the pharmaceutical industry.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~479RevenueCHF 220.6 millionOfficers31Active Relations14Deleted Relations0SOGC Records29First Record24.03.2017Latest Activity07.07.2026Pharmaceutical ManufacturingBiotechnologyResearch and DevelopmentInnovative Medicines
Registry Information
- Swiss UID
- CHE-232.876.339
- Legal Name
- Idorsia Pharmaceuticals Ltd
- Legal Form
- Limited or Corporation
- Incorporated
- 24 Mar 2017
- Share Capital
- CHF 1'000'000.00
- Canton
- BL
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Research and experimental development in the pharmaceutical industry
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001
Industry Health
Registered Address
Hegenheimermattweg 91
4123, Allschwil, BL
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients in need of innovative therapeutic options.
Competitors (1)
Novartis, Pfizer, Roche, Ipsen, Biogen, AstraZeneca, Sanofi, etc.
novartis, pfizer, roche, ipsen, biocon, regeneron pharmaceuticals, roivant sciences, csl vifor, teva, bristol-myers squibb, cipla, clinuvel, biogen, galapagos, gvk bio, rhizen, vifor (international), abbvie, abbott, noema pharma, amgen, astrazeneca, genentech, merck, bayer, gsk, sanofi
Sources (6)
